Clinical Trials in Pylaia Thessaloniki, Greece
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Bayer444 enrolled283 locationsNCT06452277
Recruiting
Phase 3
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
Neoplasms, Lung
GlaxoSmithKline420 enrolled102 locationsNCT07099898
Recruiting
Phase 1Phase 2
A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors
Tumours, Gynecological
GlaxoSmithKline392 enrolled56 locationsNCT06796907